DrugDashboards

Vancomycin Hydrochloride

Vancomycin Hydrochloride · VANCOMYCIN HYDROCHLORIDE 500 mg/10mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Eugia US LLC

NDC 55150-0203-10 · 10 VIAL in 1 CARTON / 10 mL in 1 VIAL · ANDA · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for vancomycin hydrochloride (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA205780
TE code
AP
Approval date
Mar 31, 2016
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01)Nov 14, 2025

Recalls (this NDC)

  • Class II · TerminatedNov 25, 2019
    AuroMedics Pharma LLC — Discoloration: Product complaints of discoloration after reconstitution of vials.

Manufacturers of Vancomycin Hydrochloride (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 750 mg/15mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 10 g/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 5 g/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 3, 2026
Fresenius Kabi, LLCVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 3, 2026
Hospira, Inc.VANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 3, 2026
BluePoint LaboratoriesVANCOMYCIN HYDROCHLORIDE 5 g/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesVANCOMYCIN HYDROCHLORIDE 10 g/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.VANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.VANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Civica, IncVANCOMYCIN HYDROCHLORIDE 1 g/1Jul 15, 2026Sep 2, 2026
Civica, IncVANCOMYCIN HYDROCHLORIDE 500 mg/5mLJul 15, 2026Sep 2, 2026
Civica, IncVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 1.5 g/30mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 5 g/1Jul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 1.25 g/25mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 10 g/1Jul 15, 2026Sep 2, 2026
Eurofarma, Inc.VANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Eurofarma, Inc.VANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Fresenius Kabi, LLCVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Fresenius Kabi, LLCVANCOMYCIN HYDROCHLORIDE 10 g/100mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 1.5 g/1Jul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 10 g/100mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 1.25 g/1Jul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 5 g/100mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 1.5 g/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 1.25 g/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.VANCOMYCIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN HYDROCHLORIDE 1.5 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN HYDROCHLORIDE 1.25 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 750 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Vancomycin Hydrochloride — NDC 55150-0203-10," retrieved September 3, 2026, https://drugdashboards.com/drug/55150020310.

Free to cite with attribution — see how the data is put together.